Published in Pediatr Nephrol on February 04, 2010
Off the beaten renin-angiotensin-aldosterone system pathway: new perspectives on antiproteinuric therapy. Adv Chronic Kidney Dis (2011) 0.84
Nonimmunologic targets of immunosuppressive agents in podocytes. Kidney Res Clin Pract (2015) 0.84
Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy. BMC Nephrol (2016) 0.75
Chronic cathepsin inhibition by E-64 in Dahl salt-sensitive rats. Physiol Rep (2016) 0.75
N-Degradomic Analysis Reveals a Proteolytic Network Processing the Podocyte Cytoskeleton. J Am Soc Nephrol (2017) 0.75
Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell (1998) 9.85
NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet (2000) 7.98
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet (2000) 7.39
A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science (2005) 7.03
Cell biology of the glomerular podocyte. Physiol Rev (2003) 6.85
Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol (1981) 6.84
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet (2005) 5.53
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet (2006) 5.29
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med (2008) 5.01
Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest (2004) 4.65
Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol (1997) 4.43
Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol (2007) 4.31
Three ways to make a vesicle. Nat Rev Mol Cell Biol (2000) 3.98
Progression of glomerular diseases: is the podocyte the culprit? Kidney Int (1998) 3.47
Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol (2006) 3.31
Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell (2008) 3.09
The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol (2000) 2.99
A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell (2004) 2.44
Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol (2006) 2.32
Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin. J Biol Chem (2004) 2.10
Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest (2007) 2.02
Regulating actin dynamics at membranes: a focus on dynamin. Traffic (2004) 1.96
New insights into the role of podocytes in proteinuria. Nat Rev Nephrol (2009) 1.77
Regulation of podocyte structure during the development of nephrotic syndrome. J Mol Med (Berl) (1998) 1.45
Expression of cathepsin L in human tumors. Cancer Res (1991) 1.37
Toward computer-based cleavage site prediction of cysteine endopeptidases. Biol Chem (2003) 1.27
Cyclosporin therapy in patients with Alport syndrome. Pediatr Nephrol (2006) 1.19
Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model. J Am Soc Nephrol (2003) 1.12
Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro. Biochem Biophys Res Commun (1995) 1.05
Glomerulus-specific mRNA transcripts and proteins identified through kidney expressed sequence tag database analysis. Kidney Int (2007) 1.05
Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes. Kidney Int (2002) 0.99
Treatment of focal segmental glomerulosclerosis. Expert Opin Pharmacother (2005) 0.99
Sensitizing the Slit Diaphragm with TRPC6 ion channels. J Am Soc Nephrol (2008) 0.94
The cysteine proteinase inhibitor, E-64, reduces proteinuria in an experimental model of glomerulonephritis. Biochem Biophys Res Commun (1988) 0.91
Human kidney cathepsins B and L. Characterization and potential role in degradation of glomerular basement membrane. Biochem J (1988) 0.91
An update on the treatment options for focal segmental glomerulosclerosis. Expert Opin Pharmacother (2009) 0.88
Glomerular basement membrane degradation by endogenous cysteine proteinases in isolated rat glomeruli. Kidney Int (1990) 0.84
Human chronic kidney allograft rejection is accompanied by increased intraglomerular cathepsin B and L activity. Transpl Int (1994) 0.76
A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol (2002) 6.48
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet (2005) 5.53
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med (2008) 5.01
Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med (2015) 4.85
Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19
Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol (2012) 2.83
Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest (2005) 2.39
Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet (2011) 2.38
Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol (2006) 2.32
COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest (2011) 2.21
Proteinuria: an enzymatic disease of the podocyte? Kidney Int (2009) 2.17
Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest (2007) 2.02
Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis. Transplantation (2012) 1.89
CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol (2013) 1.83
Direct dynamin-actin interactions regulate the actin cytoskeleton. EMBO J (2010) 1.67
Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Sci Signal (2011) 1.51
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J Clin Invest (2011) 1.49
Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation. Transplantation (2015) 1.47
A novel TRPC6 mutation that causes childhood FSGS. PLoS One (2009) 1.47
Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity. J Biol Chem (2008) 1.43
Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice. J Clin Invest (2010) 1.34
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int (2013) 1.33
Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol (2011) 1.30
Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med (2014) 1.26
Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome. Pediatr Nephrol (2003) 1.25
Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res (2010) 1.23
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease. PLoS One (2010) 1.18
Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood (2011) 1.17
TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol (2010) 1.14
Transient receptor potential channel 1 (TRPC1) reduces calcium permeability in heteromeric channel complexes. J Biol Chem (2011) 1.05
Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol (2014) 1.02
The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. J Mol Med (Berl) (2012) 1.02
Novel siRNA delivery system to target podocytes in vivo. PLoS One (2010) 0.96
Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J Virol (2011) 0.96
Podocyte GTPases regulate kidney filter dynamics. Kidney Int (2012) 0.96
Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance. J Clin Invest (2014) 0.94
Functional analysis of the Kv1.1 N255D mutation associated with autosomal dominant hypomagnesemia. J Biol Chem (2009) 0.94
Sensitizing the Slit Diaphragm with TRPC6 ion channels. J Am Soc Nephrol (2008) 0.94
Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. Transplantation (2013) 0.92
Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease. J Biol Chem (2013) 0.89
Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (suPAR) from a mother to child. Am J Kidney Dis (2012) 0.88
Role of podocytes in lupus nephritis. Nephrol Dial Transplant (2009) 0.88
Is there clinical value in measuring suPAR levels in FSGS? Clin J Am Soc Nephrol (2013) 0.87
The genetic basis of human glomerular disease. Adv Chronic Kidney Dis (2006) 0.87
Nephrin is expressed on the surface of insulin vesicles and facilitates glucose-stimulated insulin release. Diabetes (2009) 0.87
Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids Health Dis (2011) 0.86
Minimal change disease as a modifiable podocyte paracrine disorder. Nephrol Dial Transplant (2011) 0.86
TRPC channel modulation in podocytes-inching toward novel treatments for glomerular disease. Pediatr Nephrol (2010) 0.85
Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. Am J Ther (2013) 0.85
Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury. Biochim Biophys Acta (2013) 0.83
CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation. Nefrologia (2013) 0.83
C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potential. Stem Cells (2013) 0.82
Establishment of protein delivery systems targeting podocytes. PLoS One (2010) 0.82
In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations. Hybridoma (Larchmt) (2011) 0.82
Filtering new facts about kidney disease. Nat Med (2011) 0.82
Leptin deficiency-induced obesity affects the density of mast cells in abdominal fat depots and lymph nodes in mice. Lipids Health Dis (2012) 0.81
Novel role of mechanosensitive AT1B receptors in myogenic vasoconstriction. Pflugers Arch (2013) 0.81
Human RAGE antibody protects against AGE-mediated podocyte dysfunction. Nephrol Dial Transplant (2012) 0.81
Cellular effects of everolimus and sirolimus on podocytes. PLoS One (2013) 0.80
Novel concepts in understanding and management of glomerular proteinuria. Nephrol Dial Transplant (2002) 0.80
BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization. J Pathol (2015) 0.80
Regarding Maas's editorial letter on serum suPAR levels. Kidney Int (2012) 0.78
Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio. Nephrol Dial Transplant (2012) 0.78
Circulating factor in FSGS: a black sheep in the suPAR family? Pediatr Nephrol (2013) 0.78
Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med (2016) 0.77
Maximal 'CD80-uria' with minimal change. Kidney Int (2010) 0.77
The effect of fibrin glue on the intensity of colonic anastomosis in the presence and absence of peritonitis: an experimental randomized controlled trial on rats. ISRN Surg (2013) 0.76
Expression of trpC1 and trpC6 orthologs in zebrafish. Gene Expr Patterns (2008) 0.76
Fishing for new glomerular disease-related genes. J Am Soc Nephrol (2011) 0.76
TRPC6 in podocytes: questions and commentary on the article by Jiang et al., 'Over-expressing transient receptor potential cation channel 6 in podocytes induces cytoskeleton rearrangement through increases of intracellular Ca21 and RhoA activation'. Exp Biol Med (Maywood) (2011) 0.75
CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest (2017) 0.75
CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: response. Pediatr Nephrol (2014) 0.75
Is podocyte research at a tipping point? Report from the 9(th) International Podocyte Conference. Kidney Int (2012) 0.75
An Interferon-Induced Digital Vasculitis-Like Syndrome: A Case Report. Am J Ther (2016) 0.75